Innovation
1 patent family; filing pace active.
| Year | Filings |
|---|---|
| 2025 | 1 |
Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |
Developer of nucleic acid drugs for the treatment of infectious diseases
1 patent family; filing pace active.
| Year | Filings |
|---|---|
| 2025 | 1 |
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |